EPHA4 and amyotrophic lateral sclerosis: However, pre-symptomatic lowering of Epha4 levels in ALS mice, ubiquitously or specifically in CNS, by genetic abrogation or by administration of antisense oligonucleotides (ASOs) did not show a significant improvement in motor function, disease onset, or survival [42,43].